文献速递系统性红斑狼疮

狼疮肾炎新疗法是否足够好?叙述性综述与立场文件

How good enough are the new therapies for lupus nephritis? A narrative review and a position paper.
PubMed 文献 · Ann Rheum Dis · 2025-11-07

In this narrative review, the author, a privileged witness to exciting developments in the field of lupus nephritis over almost 4 decades, describes and comments on the new therapies that have recently become available, after years of trial failures.…

要点

  • 强调联合治疗,现获专家推荐广泛支持,以降低慢性肾病风险。
  • 评述多年试验失败后近期可用的狼疮肾炎新疗法。
  • 回顾细胞治疗早期历程并提出进一步研究思路。

核心结论

  • 强调联合治疗以降低狼疮肾炎患者慢性肾病风险,并获专家推荐广泛支持。

主要发现

  • 评述多年试验失败后近期可用的新疗法,并强调联合治疗。
  • 回顾细胞治疗早期进展并提出进一步研究方向。

临床怎么用

  • 联合治疗获专家推荐广泛支持,用于降低狼疮肾炎慢性肾病风险。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In this narrative review, the author, a privileged witness to exciting developments in the field of lupus nephritis over almost 4 decades, describes and comments on the new therapies that have recently become available, after years of trial failures. He stresses the use of combination therapy, now widely supported by expert recommendations to mitigate the risk of chronic kidney disease. He reviews the early days of cellular therapy and proposes some further lines of research.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Houssiau FA. How good enough are the new therapies for lupus nephritis? A narrative review and a position paper. Ann Rheum Dis. 2025. PMID: 41206245. doi:10.1016/j.ard.2025.10.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。